Model-Based Prediction of Acid Suppression and Proposal of a New Dosing Regimen of Fexuprazan in Humans

• Κύριοι συγγραφείς: Min-Soo Kim (Συγγραφέας), Nora Lee (Συγγραφέας), Areum Lee (Συγγραφέας), Yoon-Jee Chae (Συγγραφέας), Suk-Jae Chung (Συγγραφέας), Kyeong-Ryoon Lee (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2022-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Fexuprazan is a potassium-competitive acid blocker (P-CAB). The compounds in this newly developed drug family suppress intragastric acidity. As there are already other acid-suppressing drugs on the market, such as H₂ antagonists and proton pump inhibitors (PPIs), it would be i...